Fuller & Thaler Asset Management Inc. acquired a new stake in shares of Humana Inc (NYSE:HUM) in the third quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,300 shares of the insurance provider’s stock, valued at approximately $317,000.

Other hedge funds also recently bought and sold shares of the company. Koch Industries Inc. bought a new position in Humana during the 2nd quarter valued at approximately $404,000. Adviser Investments LLC bought a new position in Humana during the 3rd quarter valued at approximately $635,000. Teachers Advisors LLC increased its holdings in shares of Humana by 31.6% in the 2nd quarter. Teachers Advisors LLC now owns 630,835 shares of the insurance provider’s stock worth $151,792,000 after purchasing an additional 151,603 shares in the last quarter. Prisma Capital Partners LP bought a new stake in shares of Humana in the 2nd quarter worth $7,122,000. Finally, Federated Investors Inc. PA increased its holdings in shares of Humana by 608.1% in the 2nd quarter. Federated Investors Inc. PA now owns 34,626 shares of the insurance provider’s stock worth $8,331,000 after purchasing an additional 29,736 shares in the last quarter. 96.70% of the stock is owned by institutional investors.

Humana Inc (HUM) opened at $240.51 on Friday. Humana Inc has a 52-week low of $186.25 and a 52-week high of $264.56. The company has a market capitalization of $34,359.26, a PE ratio of 20.52, a PEG ratio of 1.65 and a beta of 0.91. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.61 and a quick ratio of 1.61.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.27 by $0.12. Humana had a return on equity of 15.99% and a net margin of 3.49%. The business had revenue of $13.28 billion for the quarter, compared to the consensus estimate of $13.41 billion. During the same period in the previous year, the business earned $3.18 earnings per share. The business’s revenue was down 3.0% on a year-over-year basis. sell-side analysts predict that Humana Inc will post 11.63 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be given a $0.40 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.67%. Humana’s payout ratio is 12.59%.

In other news, VP Timothy S. Huval sold 7,803 shares of Humana stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $258.14, for a total value of $2,014,266.42. Following the sale, the vice president now directly owns 8,831 shares of the company’s stock, valued at $2,279,634.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Elizabeth D. Bierbower sold 9,786 shares of Humana stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $259.00, for a total value of $2,534,574.00. Following the completion of the sale, the insider now directly owns 18,042 shares in the company, valued at $4,672,878. The disclosure for this sale can be found here. 0.80% of the stock is owned by insiders.

A number of research firms have commented on HUM. UBS AG reissued a “neutral” rating and issued a $250.00 target price (up previously from $237.00) on shares of Humana in a report on Wednesday, August 9th. BidaskClub raised Humana from a “sell” rating to a “hold” rating in a report on Wednesday, August 23rd. Cantor Fitzgerald restated a “neutral” rating and issued a $223.00 price target (up from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Morgan Stanley raised their price target on Humana from $269.00 to $276.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Finally, Jefferies Group LLC restated a “hold” rating and issued a $257.00 price target on shares of Humana in a research note on Friday, August 4th. Thirteen analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. Humana has a consensus rating of “Hold” and an average price target of $252.81.

WARNING: “Fuller & Thaler Asset Management Inc. Invests $317,000 in Humana Inc (HUM) Stock” was published by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/fuller-thaler-asset-management-inc-invests-317000-in-humana-inc-hum-stock/1727408.html.

Humana Company Profile

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.